Detecting Aquaporin 4 Antibodies for Neuromyelitis Optica Diagnosis
Author Information
Author(s): Paul Friedemann, Sven Jarius, Orhan Aktas, Martin Bluthner, Oliver Bauer, Heribert Appelhans, Diego Franciotta, Roberto Bergamaschi, Edward Littleton, Jacqueline Palace, Hans-Peter Seelig, Reinhard Hohlfeld, Angela Vincent, Frauke Zipp
Primary Institution: Cecilie-Vogt-Clinic for Molecular Neurology, Charité, University Medicine Berlin, Berlin, Germany
Hypothesis
AQP4 antibodies characterize NMO patients.
Conclusion
The study shows that AQP4 antibodies can help distinguish between neuromyelitis optica and multiple sclerosis.
Supporting Evidence
- 21 out of 37 NMO patients tested positive for AQP4 antibodies.
- 6 out of 6 LETM patients tested positive for AQP4 antibodies.
- Only 5 out of 291 control samples tested positive for AQP4 antibodies.
Takeaway
Doctors can use a new test to find specific antibodies in blood that help tell if someone has a disease called neuromyelitis optica instead of multiple sclerosis.
Methodology
The study used a radioimmunoprecipitation assay to measure AQP4 antibodies in patient serum samples.
Limitations
The assay has moderate interassay variation, which may affect results.
Participant Demographics
Included 37 NMO patients, 6 LETM patients, and 291 controls from various neurological conditions.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website